EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiota and Metabolites: Biomarkers and Therapeutic Targets for Diabetes Mellitus and Its Complications

Kai Yan, Xin Sun, Xin Wang, Jing Zheng, Hongsong Yu

Nutrients · 11.08.2025 · 17 (16) · 2603

DOI: 10.3390/nu17162603 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 11.08.2025. Verfasst von Kai Yan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Special Key Laboratory of Ocular Diseases of Guizhou Province, Department of Immunology, Zunyi Medical University, Zunyi 563000, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Diabetes Mellitus, Diabetes Complications. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 236 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Young Talents of Zunyi Medical University, Key Construction Discipline of Immunology and Pathogen Biology in Zhuhai Campus of Zunyi Medical University, Excellent Young Talents of Zunyi Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) is a complex metabolic disease characterized by significantly elevated blood glucose levels as a result of dysfunctional or impaired pancreatic β-cells, leading to insulin deficiency. This condition can result in severe complications, including cardiovascular diseases, kidney failure, vision impairment, and nerve damage. Currently available anti-diabetic drugs do not fully prevent the progression of these complications. Moreover, they often have significant side effects. The gut microbiota plays a crucial role in influencing diet, energy metabolism, and blood glucose levels. Research shows a strong link between microbiota dysbiosis and DM, as well as the severity of its complications. Commensal bacteria can help manage blood glucose levels, reduce inflammation, regulate metabolism, and enhance the gut barrier. Conversely, opportunistic pathogens can worsen insulin resistance, promote metabolic disorders, disrupt gut integrity, and affect appetite and weight. This article describes the characteristics of gut microbiota in various types of DM and explores the role of the “gut microbiota–metabolite–signaling pathway” axis in DM and its complications. In addition, it highlights the therapeutic potential of traditional Chinese medicine and dietary interventions through modulation of the gut microbiota and metabolites. The aim is to provide comprehensive evidence supporting the integration of TCM dietary therapy, targeted dietary strategies, and specific probiotics as alternative and complementary therapies for DM and its complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDiabetes MellitusDiabetes ComplicationsHumansBiomarkersDysbiosisProbioticsMedicine, Chinese TraditionalBlood Glucose

Stichwörter der Autor:innen

diabetes mellitusdiabetic complicationsdietsgut microbiotatraditional Chinese medicine

Substanzen

BiomarkersBlood Glucose

Autor:innen und Institutionen

  • Special Key Laboratory of Ocular Diseases of Guizhou Province, Department of Immunology, Zunyi Medical University, Zunyi 563000, China.
  • Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, School of Basic Medical Sciences, Zunyi Medical University, Zunyi 563000, China.

Förderung

  • Foundation for Young Talents of Zunyi Medical University
  • Key Construction Discipline of Immunology and Pathogen Biology in Zhuhai Campus of Zunyi Medical University
  • Excellent Young Talents of Zunyi Medical University
  • Hundred-level Innovative Talent Foundation of Guizhou
  • Natural Science Foundation Project of China
  • Graduate fund project of Guizhou
  • National Natural Science Foundation Project of China
  • Hundred-level Innovative Talent Foundation of Guizhou Province

Zitieren

APA

Yan, K., Sun, X., Wang, X., Zheng, J., & Yu, H. (2025). Gut Microbiota and Metabolites: Biomarkers and Therapeutic Targets for Diabetes Mellitus and Its Complications. Nutrients, 17(16), 2603. https://doi.org/10.3390/nu17162603

Vancouver

Yan K, Sun X, Wang X, Zheng J, Yu H. Gut Microbiota and Metabolites: Biomarkers and Therapeutic Targets for Diabetes Mellitus and Its Complications. Nutrients. 2025;17(16):2603. doi:10.3390/nu17162603

BibTeX
@article{Yan2025,
  author = {Yan, Kai and Sun, Xin and Wang, Xin and Zheng, Jing and Yu, Hongsong},
  title = {Gut Microbiota and Metabolites: Biomarkers and Therapeutic Targets for Diabetes Mellitus and Its Complications},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {16},
  pages = {2603},
  doi = {10.3390/nu17162603}
}
Kostenlos starten →